NEW YORK (GenomeWeb News) – Microfluidic Systems yesterday said that it will use Applied Biosystems’ TaqMan assays in its Bioagent Autonomous Networked Detector for airborne pathogens.
Microfluidic Systems said that ABI will manufacture the assays, which can be used for detecting harmful pathogens. It noted that ABI’s TaqMan assays have provided more than 5.2 million anthrax screening tests through ongoing mail-screening applications.
The US Department of Homeland Security’s Science and Technology Directorate has been funding development of BAND for the past three years. The goal of the program is to monitor air quality in cities or large regions for biosecurity threats, such as anthrax, plague, and smallpox.
Under a separate agreement also announced today, the Hamilton Sundstrand unit of United Technologies will provide design for manufacturing, pilot production, high-volume manufacturing, and product support of the BAND system.